Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| PRAD | rs8040152 | chr15:83356728 | C/T | 4.1E-7 | 493 | 31.18 | 30.33 | 29.08 | KM Plot |
| PRAD | rs8054222 | chr16:3413477 | C/T | 0.000102 | 494 | 28.87 | 35.47 | 26.27 | KM Plot |
| PRAD | rs8064344 | chr17:76876974 | C/T | 2.74E-8 | 486 | 23.2 | 32.92 | 30.77 | KM Plot |
| PRAD | rs8065599 | chr17:76877073 | T/C | 2.74E-8 | 486 | 23.2 | 32.92 | 30.77 | KM Plot |
| PRAD | rs8071084 | chr17:79634162 | T/G | 4.36E-5 | 488 | 30.78 | 31.37 | 25.67 | KM Plot |
| PRAD | rs8088602 | chr18:72789420 | A/C | 2.76E-5 | 494 | 31.23 | 30.2 | 13.47 | KM Plot |
| PRAD | rs810027 | chr1:93852395 | A/G | 3.53E-6 | 494 | 31.3 | 28.67 | 18.97 | KM Plot |
| PRAD | rs8117291 | chr20:61680815 | G/A | 7.13E-6 | 490 | 31.07 | 30.78 | 24.15 | KM Plot |
| PRAD | rs812666 | chr4:185197061 | A/G | 0.00019 | 494 | 30.85 | 31.37 | 28.07 | KM Plot |
| PRAD | rs8135939 | chr22:18434284 | A/G | 6.96E-6 | 484 | 29.17 | 32.98 | 26.37 | KM Plot |
| PRAD | rs8142673 | chr22:42596253 | A/C | 2.93E-11 | 494 | 11.13 | 24.55 | 31.38 | KM Plot |
| PRAD | rs814421 | chr8:9940481 | A/C | 0.00017 | 494 | 22.67 | 31.27 | 31.32 | KM Plot |
| PRAD | rs814427 | chr8:9947323 | G/C | 3.3E-5 | 490 | 19.3 | 30.97 | 31.87 | KM Plot |
| PRAD | rs831745 | chr1:201130286 | T/A | 6.28E-9 | 491 | 43.53 | 30.8 | 30.77 | KM Plot |
| PRAD | rs831746 | chr1:201130814 | A/C | 8.72E-8 | 494 | 43.53 | 30.8 | 30.78 | KM Plot |